Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-5
Publisher
Informa UK Limited
Online
2020-04-30
DOI
10.1080/21645515.2020.1749509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Herpesvirus membrane fusion – a team effort
- (2020) Benjamin Vollmer et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
- (2019) Sita Awasthi et al. Science Immunology
- Time Trends in First-Episode Genital Herpes Simplex Virus Infections in an Urban Sexually Transmitted Disease Clinic
- (2019) Nazila Dabestani et al. SEXUALLY TRANSMITTED DISEASES
- An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
- (2017) Sita Awasthi et al. PLoS Pathogens
- A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
- (2015) Sita Awasthi et al. JOURNAL OF VIROLOGY
- Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
- (2015) Marina Boukhvalova et al. JOURNAL OF VIROLOGY
- Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
- (2015) Katharine J. Looker et al. PLoS One
- Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012
- (2015) Katharine J. Looker et al. PLoS One
- Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine
- (2014) Sita Awasthi et al. JOURNAL OF INFECTIOUS DISEASES
- Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes
- (2014) S. Awasthi et al. JOURNAL OF VIROLOGY
- Status of prophylactic and therapeutic genital herpes vaccines
- (2014) Sita Awasthi et al. Current Opinion in Virology
- Efficacy Results of a Trial of a Herpes Simplex Vaccine
- (2012) Robert B. Belshe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Herpes Virus Fusion and Entry: A Story with Many Characters
- (2012) Roselyn J. Eisenberg et al. Viruses-Basel
- Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection
- (2011) Elizabeth Tronstein JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo
- (2011) J. M. Lubinski et al. JOURNAL OF VIROLOGY
- Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
- (2011) S. Awasthi et al. JOURNAL OF VIROLOGY
- A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine
- (2008) E. E. Brittle et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More